US20080167709A1 - Stent and Method for Manufacturing the Same - Google Patents

Stent and Method for Manufacturing the Same Download PDF

Info

Publication number
US20080167709A1
US20080167709A1 US11/914,490 US91449006A US2008167709A1 US 20080167709 A1 US20080167709 A1 US 20080167709A1 US 91449006 A US91449006 A US 91449006A US 2008167709 A1 US2008167709 A1 US 2008167709A1
Authority
US
United States
Prior art keywords
peaks
cylindrical
valleys
stent
manufacturing frame
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US11/914,490
Inventor
Sung-soon An
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
STANDARD SCI-TECH Inc
Original Assignee
STANDARD SCI-TECH Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by STANDARD SCI-TECH Inc filed Critical STANDARD SCI-TECH Inc
Assigned to STANDARD SCI-TECH, INC. reassignment STANDARD SCI-TECH, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: AN, SUNG-SOON
Assigned to STANDARD SCI-TECH, INC. reassignment STANDARD SCI-TECH, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: AN, SUNG-SOON
Publication of US20080167709A1 publication Critical patent/US20080167709A1/en
Priority to US13/012,946 priority Critical patent/US8210084B2/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/89Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure the wire-like elements comprising two or more adjacent rings flexibly connected by separate members
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2240/00Manufacturing or designing of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2240/001Designing or manufacturing processes
    • DTEXTILES; PAPER
    • D10INDEXING SCHEME ASSOCIATED WITH SUBLASSES OF SECTION D, RELATING TO TEXTILES
    • D10BINDEXING SCHEME ASSOCIATED WITH SUBLASSES OF SECTION D, RELATING TO TEXTILES
    • D10B2509/00Medical; Hygiene
    • D10B2509/06Vascular grafts; stents

Definitions

  • the present invention relates to a stent and a method for manufacturing the same, and more particularly, to the stent that is improved in a quality by preventing the damage of a material thereof during a manufacturing process and a method for manufacturing the stent.
  • a stent may be inserted into a lumen of a human body, or into a lesion of a blood vessel in order to maintain a passageway of the lumen, or the blood vessel.
  • the stent may be formed of a shape memory alloy such as nitinol maintaining a uniform expansion force at a temperature of the lumen.
  • the stent may be formed in a cylindrical shape woven by wires, and the cylindrical stent may be formed of two thin long members successively woven repeatedly in order to have a good expansion force (elastic force) in a radial direction. That is, a plurality of pins are disposed on a cylindrical manufacturing frame. Distances between the pins are same as each other.
  • the two thin, long members each having a length of several meters are woven one after the other on the pins repeatedly.
  • the thin, long members may be a wire member. At this point, during one member is woven, the other is in a standby status.
  • the other wire member is left twisted or waved. Therefore, the wire members may be damaged during the above-described process, thereby being reduced in their elastic force and thus deteriorating the quality of the product.
  • the present invention has been made in an effort to solve the above-described problems. It is an object of the present invention to provide a method of manufacturing a stent, which can prevent the wire members from being damaged during manufacturing processes of the stent, thereby improving the quality of the products.
  • Another object of the present invention is to provide a stent that can maintain the elastic force in a radial direction thereby easily inserted into or removed from the lesion and can prevent itself from inadvertently moving away from the lesion, thereby increasing a healing effect on a patient and a method for manufacturing the stent.
  • Still another object of the present invention is to provide a stent that is reduced in a diameter to a desired level when it is to be inserted in the lesion and thus can be easily inserted using an introducer, thereby reducing a pain of a patient and a method for manufacturing the stent.
  • the present invention provides a method of manufacturing a stent, including: forming a first cylindrical mesh structure by bending a first member in a zigzag-shape having peaks and valleys and a plurality of turns wound around an outer circumference of a manufacturing frame; and forming a second cylindrical mesh structure by bending a second member in a zigzag-shape having peaks and valleys and a plurality of turns wound around an outer circumference of a manufacturing frame, wherein a bending track the second member crosses a bending track of the first member.
  • the method may further include, after the first cylindrical mesh structure is formed, forming a first strut formed of a spirally twisted strut that is formed at a point where a distal end of the first member meets a proximal end of the first member.
  • the method may further include, after the second cylindrical mesh structure is formed, forming a second strut formed of a spirally twisted strut that is formed at a point where a distal end of the second member meets a proximal end of the second member.
  • the peaks and valleys of different turns of the first member are crossed and interlocked each other when the peaks and valleys of the different turns of the first member meet each other during the first cylindrical mesh structure is formed.
  • the peaks and valleys of different turns of the second member are crossed and interlocked each other when the peaks and valleys of different turns of the second member meet each other during the second cylindrical mesh structure is formed.
  • a method of manufacturing a stent including: providing a plurality of pins on a cylindrical surface of a cylindrical manufacturing frame and setting one of a plurality of pins as a starting point; winding a first member around the cylindrical manufacturing frame from the starting point to an end of the cylindrical manufacturing frame while being bent in a zigzag-shape to form peaks and valley with reference to the pins and having a plurality of turns; winding the first member around the cylindrical manufacturing frame from the end of the cylindrical manufacturing frame to the starting point while being bent in a zigzag-shape to form peaks and valley with reference to the pins and having a plurality of turns, the peaks and valley are crossed and interlocked each other when the peaks and valleys meet each other; forming a strut by spirally twisting a distal end portion of the first member and a proximal end portion of the first member after the peaks and valleys of the first member are formed; winding a second member around
  • a stent including: a first cylindrical mesh structure formed by bending a first member in a zigzag-shape having peaks and valleys and a plurality of turns wound around an outer circumference of a manufacturing frame; and a second cylindrical mesh structure formed by bending a second member in a zigzag-shape having peaks and valleys and a plurality of turns wound around an outer circumference of a manufacturing frame, wherein a bending track the second member crosses a bending track of the first member, wherein the first cylindrical mesh structure includes a first strut formed of a spirally twisted strut that is formed at a point where a distal end of the first member meets a proximal end of the first member; and the second cylindrical mesh structure includes a second strut formed of a spirally twisted strut that is formed at a point where a distal end of the second member meets a proximal end of the second member.
  • the peaks and valleys of the first and second members are crossed and interlocked each other as a hook shape when they meet each other.
  • a cylindrical stent with big mesh sizes is formed of the first member. After then the second member is crossed the track of the first member in order to form a cylindrical stent with small mesh sizes. Therefore, inadvertent displace of the first and second members from a target place can be prevented, and damages of materials forming of the first and second members are reduced thereby producing qualitative products.
  • the distal end of the first member is continuously twisted around a part of the first member in order to form the first spirally twisted strut
  • the distal end of the second member is continuously twisted around a part of the second member in order to form the second spirally twisted strut. Therefore, the spirally twisted struts increase an elastic force from a center to a radial direction. Also, when the stent is inserted to the lesion, the stent minimizes moving or overlapping to a longitudinal direction thereby the stent may be inserted easily. In addition, the increased elastic force of the stent to the radial direction maintains the stent fixed status at the lesion thereby maximizing the healing effect on a patient by preventing the stent moving from the lesion.
  • the first and second members have a crossed structure when the first and second members meet each other thereby minimizing a diameter of the stent.
  • the stent has the minimum diameter, the stent has the minimum volume. Therefore, the stent may be inserted easily using the introducer thereby reducing the pain of a patient.
  • FIG. 1 is a perspective view illustrating a first embodiment of the present invention.
  • FIGS. 2 through 7 are developed views illustrating a working procedure of a first process.
  • FIGS. 8 through 14 are exploded views illustrating a working procedure of a second process.
  • FIG. 1 is a perspective view of a stent manufactured by a method of the present invention.
  • FIGS. 2 through 14 are views illustrating consecutive processes of manufacturing the stent.
  • a stent is formed of first and second members 1 and 3 .
  • FIGS. 2 through 7 are views illustrating a process, in which the cylindrical stent is formed of the first member on a manufacturing frame.
  • FIGS. 8 through 14 are views illustrating a process, in which a fine mesh structure is formed of the second member. The fine mesh structure is formed on the cylindrical stent formed of the first member.
  • the first and second members 1 and 3 may be formed of a wire member, which may be coated in order to be inserted into a lumen or a lesion of a human body for a medical use.
  • the method of manufacturing the stent using a manufacturing frame J will be described in detail.
  • the manufacturing frame J is cylindrical, and a plurality of pins P are disposed on a cylindrical surface on which the plurality of pins protrude in a radial direction.
  • the gaps between the plurality of pins are same as each other, but the plurality of pins may be disposed with different gaps according to a design of the stent.
  • It is preferable a plurality of holes are formed on the manufacturing frame J, and the plurality of pins are inserted into the plurality of holes. Referring to FIG.
  • 9 rows of the plurality of pins are disposed in the longitudinal direction of the stent.
  • 9 rows are arbitrary.
  • 14 pins are disposed on the first row x 1 and the last row x 9 .
  • Gaps between the 14 pins in the radial direction of the manufacturing frame J are identical to each other.
  • 7 pins (y 1 , y 3 , y 5 , y 7 , y 9 , y 11 , y 13 ) are disposed on the rows from x 2 to x 8 .
  • the number of pins disposed on the manufacturing frame j is not limited to this embodiment, and the stent may be manufactured using different numbers of pins.
  • Peaks and valleys are formed of the first member 1 successively from x 1 to x 9 , in which the starting point is x 1 y 5 .
  • the peaks and valleys of the first member are formed along the cylindrical surface of the manufacturing frame J, wherein a track of the first member 1 is bent zigzag. That is, referring to FIG. 2 , the track of the first member 1 passes the points x 3 y 3 , x 1 y 1 , x 3 y 13 , x 1 y 11 , x 3 y 9 , x 1 y 7 , x 5 y 3 , x 3 y 1 , x 5 y 13 , x 3 y 11 , . . .
  • Peaks and valleys are formed of the first member 1 successively from x 9 to x 1 along the cylindrical surface of the manufacturing frame J, wherein a track of the first member 1 is bent zigzag. That is, the track of the first member 1 is continued to pass the points x 7 y 7 , x 9 y 5 , x 7 y 3 , x 9 y 1 , x 7 y 13 , x 9 y 11 , x 7 y 9 , x 9 y 7 , and x 5 y 3 .
  • the first member 1 When the track of the first member 1 passes the points x 7 y 3 , x 7 y 13 , x 7 y 9 , and x 5 y 3 at which the peaks and valley meet each other, the first member 1 may be crossed and interlocked simultaneously to the preceding first member in order to keep connected status. It is preferable peaks and valleys are crossed and interlocked simultaneously when peaks and valleys meet each other, and hereinafter this description may be omitted sometimes.
  • the track of the peaks and valleys of the first member 1 is continuously formed on the cylindrical surface of the manufacturing frame. That is, referring FIG. 4 , the track of the first member 1 passes continuously the points x 5 y 3 , x 7 y 1 , x 5 y 13 , x 7 y 11 , x 5 y 9 , x 7 y 7 , and x 3 y 3 in order to form the stent. Also, referring FIG.
  • the track of the first member 1 passes continuously the points x 3 y 3 , x 5 y 1 , x 3 y 13 , x 5 y 11 , x 3 y 9 , x 5 y 7 , and x 1 y 3 in order to form the stent.
  • the track of the first member 1 passes continuously the points x 1 y 3 , x 3 y 1 , x 1 y 13 , x 3 y 11 , x 1 y 9 , x 3 y 7 , and x 1 y 5 (the starting point) in order to form the stent.
  • the track of the first member 1 forms the peaks and valleys on the cylindrical surface of the manufacturing frame J starting from the starting point (x 1 y 5 ).
  • the track of the first member 1 passes from the first row to the last row.
  • the track of the first member 1 continuously passes from the last row to the first row, and the track of the first member 1 meets the preceding first member 1 at the starting point (x 1 y 5 ).
  • peaks and valleys are crossed and interlocked simultaneously whenever peaks and valleys meet each other.
  • a spirally twisted strut ( 1 a ) is formed around the preceding first member at the starting point x 1 y 5 .
  • the strut ( 1 a ) increases an elastic force in radial and longitudinal directions, thereby reducing a longitudinal shrinkage when the stent is inserted. Therefore, the stent may be inserted easily, and the stent may keep a fixed status at the lesion with stability.
  • FIGS. 8 through 14 are views illustrating process for reducing a mesh size of the stent formed of the first member 1 using the second member 3 . That is, it is preferable the second member 3 starts from the point x 1 y 12 . The point x 1 y 12 is a symmetrically opposite location of the starting point x 1 y 5 of the first member 1 . Also, it is preferable the second member 3 crosses about half of the meshes formed by the first member 1 , when the cylindrical stent is formed of the second member 3 . This will now be described more fully with reference to FIGS. 8 through 14 .
  • Peaks and valleys are formed of the second member 3 starting from the point x 1 y 12 along the cylindrical surface of the manufacturing frame J, wherein a track of the second member 3 is bent zigzag from x 1 to x 9 successively. At this point, it is preferable the second member 3 crosses about a half of the each mesh formed of the first member 1 in order to form meshes of half size.
  • the track of the second member 3 passes the points x 1 y 12 , x 4 y 9 , x 2 y 7 , x 4 y 5 , x 2 y 3 , x 4 y 1 , x 2 y 13 , x 6 y 9 , x 4 y 7 , x 6 y 5 , x 4 y 3 , . . . x 6 y 13 , and x 9 y 10 .
  • peaks and valleys are formed of the second member 3 along the cylindrical surface of the manufacturing frame J, wherein a track of the second member 3 is bent zigzag from x 9 to x 1 successively.
  • the track of the second member 3 is continued to pass the points x 9 y 10 , x 8 y 9 , x 9 y 8 , x 8 y 7 , x 9 y 6 , x 8 y 5 , x 9 y 4 , x 8 y 3 , x 9 y 8 , x 8 y 1 , x 9 y 14 , x 8 y 13 , x 9 y 12 , and x 6 y 9 .
  • the second member 3 may be crossed and interlocked simultaneously in order to keep connected status. It is preferable peaks and valleys are crossed and interlocked simultaneously whenever peaks and valleys meet each other.
  • the peaks and valleys of the second member 3 are formed on the cylindrical surface of the manufacturing frame. That is, referring FIG. 10 , the track of the second member 3 passes continuously the points x 6 y 9 , x 8 y 7 , x 6 y 5 , x 8 y 3 , x 6 y 1 , x 8 y 13 , and x 4 y 9 in order to form the stent. Also, referring to FIG.
  • the track of the second member 3 further passes continuously the points x 4 y 9 , x 6 y 7 , x 4 y 5 , x 6 y 3 , x 4 y 1 , x 6 y 13 , and x 2 y 9 in order to form the stent.
  • the track of the second member 3 further passes continuously the points x 4 y 9 , x 6 y 7 , x 4 y 5 , x 6 y 3 , x 4 y 1 , x 6 y 13 , and x 2 y 9 in order to form the stent.
  • the track of the second member 3 further passes continuously the points x 1 y 10 , x 2 y 9 , x 1 y 8 , x 2 y 7 , x 1 y 6 , x 2 y 5 , x 1 y 4 , x 2 y 3 , x 1 y 2 , x 2 y 1 , x 1 y 14 , x 2 y 13 , and x 1 y 12 (the starting point of the second member 3 ) in order to form the stent.
  • the track of the second member 3 forms the peaks and valleys on the cylindrical surface of the manufacturing frame J starting from the starting point x 1 y 12 (x 1 y 12 is a symmetrically opposite point of the starting point of the first member on the cylindrical surface). At this point, the track of the second member 3 passes from the first row to the last row. After then the track of the second member 3 continuously passes from the last row to the first row, and the track of the second member 3 meets the preceding second member 3 at the starting point x 1 y 12 . It is preferable, according to the present invention, peaks and valleys are crossed and interlocked simultaneously when peaks and valleys meet each other.
  • another spirally twisted strut ( 3 a ) is formed around the preceding second member at the starting point x 1 y 12 .
  • the strut ( 3 a ) increases an elastic force in radial and longitudinal directions, thereby reducing the longitudinal shrinkage when the stent is inserted. Therefore, the stent may be inserted easily, and the stent may keep a fixed status at the lesion with stability. It is preferable the struts ( 1 a and 3 a ) are disposed as symmetric spirals.
  • the processes for the second member are conducted after the processes for the first member 1 are completed. Accordingly, the first and second members 1 and 3 may not be interlocked each other simultaneously, and unprocessed part (the end part of the first and second members that may be wire members) of the first and second members 1 and 3 may not be damaged during the manufacturing processes. Therefore, a working efficiency is increased, and a quality of products may be improved. Specially, the manufacturing method of the present invention may form a finer mesh structure with an easy working process and thus the quality of the stent may be more improved.
  • the first and second members 1 and 3 are crossed and interlocked each other when they meet each other. Accordingly, when the stent is constricted, the stent has a smaller diameter than a stent formed by the prior art in which peaks and valleys are continuously interlocked each other without crossing points. Therefore, according to the present invention, the stent may be inserted using an introducer having a smaller diameter.
  • the stent may be used in a field of medical equipments. That is, the stent may be inserted into a lumen of a human body, or into a lesion of a blood vessel in order to maintain a passageway of the lumen, or the blood vessel.

Abstract

A method of manufacturing a stent includes forming a first cylindrical mesh structure by bending a first member in a zigzag-shape having peaks and valleys and a plurality of turns wound around an outer circumference of a manufacturing frame and forming a second cylindrical mesh structure by bending a second member in a zigzag-shape having peaks and valleys and a plurality of turns wound around an outer circumference of a manufacturing frame, wherein a bending track the second member crosses a bending track of the first member.

Description

    TECHNICAL FIELD
  • The present invention relates to a stent and a method for manufacturing the same, and more particularly, to the stent that is improved in a quality by preventing the damage of a material thereof during a manufacturing process and a method for manufacturing the stent.
  • BACKGROUND ART
  • Generally, a stent may be inserted into a lumen of a human body, or into a lesion of a blood vessel in order to maintain a passageway of the lumen, or the blood vessel. The stent may be formed of a shape memory alloy such as nitinol maintaining a uniform expansion force at a temperature of the lumen. The stent may be formed in a cylindrical shape woven by wires, and the cylindrical stent may be formed of two thin long members successively woven repeatedly in order to have a good expansion force (elastic force) in a radial direction. That is, a plurality of pins are disposed on a cylindrical manufacturing frame. Distances between the pins are same as each other. The two thin, long members each having a length of several meters are woven one after the other on the pins repeatedly. The thin, long members may be a wire member. At this point, during one member is woven, the other is in a standby status.
  • However, during one wire member is woven, the other wire member is left twisted or waved. Therefore, the wire members may be damaged during the above-described process, thereby being reduced in their elastic force and thus deteriorating the quality of the product.
  • DISCLOSURE OF INVENTION Technical Problem
  • The present invention has been made in an effort to solve the above-described problems. It is an object of the present invention to provide a method of manufacturing a stent, which can prevent the wire members from being damaged during manufacturing processes of the stent, thereby improving the quality of the products.
  • Another object of the present invention is to provide a stent that can maintain the elastic force in a radial direction thereby easily inserted into or removed from the lesion and can prevent itself from inadvertently moving away from the lesion, thereby increasing a healing effect on a patient and a method for manufacturing the stent.
  • Still another object of the present invention is to provide a stent that is reduced in a diameter to a desired level when it is to be inserted in the lesion and thus can be easily inserted using an introducer, thereby reducing a pain of a patient and a method for manufacturing the stent.
  • Technical Solution
  • In order to achieve the above-described objects, the present invention provides a method of manufacturing a stent, including: forming a first cylindrical mesh structure by bending a first member in a zigzag-shape having peaks and valleys and a plurality of turns wound around an outer circumference of a manufacturing frame; and forming a second cylindrical mesh structure by bending a second member in a zigzag-shape having peaks and valleys and a plurality of turns wound around an outer circumference of a manufacturing frame, wherein a bending track the second member crosses a bending track of the first member.
  • Preferably, the method may further include, after the first cylindrical mesh structure is formed, forming a first strut formed of a spirally twisted strut that is formed at a point where a distal end of the first member meets a proximal end of the first member.
  • Preferably, the method may further include, after the second cylindrical mesh structure is formed, forming a second strut formed of a spirally twisted strut that is formed at a point where a distal end of the second member meets a proximal end of the second member.
  • Preferably, the peaks and valleys of different turns of the first member are crossed and interlocked each other when the peaks and valleys of the different turns of the first member meet each other during the first cylindrical mesh structure is formed.
  • Preferably, the peaks and valleys of different turns of the second member are crossed and interlocked each other when the peaks and valleys of different turns of the second member meet each other during the second cylindrical mesh structure is formed.
  • According to another aspect of the present invention, there is provided a method of manufacturing a stent, including: providing a plurality of pins on a cylindrical surface of a cylindrical manufacturing frame and setting one of a plurality of pins as a starting point; winding a first member around the cylindrical manufacturing frame from the starting point to an end of the cylindrical manufacturing frame while being bent in a zigzag-shape to form peaks and valley with reference to the pins and having a plurality of turns; winding the first member around the cylindrical manufacturing frame from the end of the cylindrical manufacturing frame to the starting point while being bent in a zigzag-shape to form peaks and valley with reference to the pins and having a plurality of turns, the peaks and valley are crossed and interlocked each other when the peaks and valleys meet each other; forming a strut by spirally twisting a distal end portion of the first member and a proximal end portion of the first member after the peaks and valleys of the first member are formed; winding a second member around the cylindrical manufacturing frame from a starting point to an end of the cylindrical manufacturing frame while being bent in a zigzag-shape to form peaks and valley with reference to the pins and having a plurality of turns, wherein the starting point of the second member is disposed on a symmetrically opposite location of the starting point of the first member on the surface of the cylindrical manufacturing frame; winding the second member around the cylindrical manufacturing frame from the end of the cylindrical manufacturing frame to the starting point while being bent in a zigzag-shape to form peaks and valley with reference to the pins and having a plurality of turns, the peaks and valley are crossed and interlocked each other when the peaks and valleys meet each other; forming a strut by spirally twisting a distal end portion of the second member and a proximal end portion of the first member after the peaks and valleys of the first member are formed.
  • According to still another aspect of the present invention, there is provided a stent including: a first cylindrical mesh structure formed by bending a first member in a zigzag-shape having peaks and valleys and a plurality of turns wound around an outer circumference of a manufacturing frame; and a second cylindrical mesh structure formed by bending a second member in a zigzag-shape having peaks and valleys and a plurality of turns wound around an outer circumference of a manufacturing frame, wherein a bending track the second member crosses a bending track of the first member, wherein the first cylindrical mesh structure includes a first strut formed of a spirally twisted strut that is formed at a point where a distal end of the first member meets a proximal end of the first member; and the second cylindrical mesh structure includes a second strut formed of a spirally twisted strut that is formed at a point where a distal end of the second member meets a proximal end of the second member.
  • Preferably, the peaks and valleys of the first and second members are crossed and interlocked each other as a hook shape when they meet each other.
  • Advantageous Effects
  • According to the present invention, a cylindrical stent with big mesh sizes is formed of the first member. After then the second member is crossed the track of the first member in order to form a cylindrical stent with small mesh sizes. Therefore, inadvertent displace of the first and second members from a target place can be prevented, and damages of materials forming of the first and second members are reduced thereby producing qualitative products.
  • In addition, according to the present invention, the distal end of the first member is continuously twisted around a part of the first member in order to form the first spirally twisted strut, and the distal end of the second member is continuously twisted around a part of the second member in order to form the second spirally twisted strut. Therefore, the spirally twisted struts increase an elastic force from a center to a radial direction. Also, when the stent is inserted to the lesion, the stent minimizes moving or overlapping to a longitudinal direction thereby the stent may be inserted easily. In addition, the increased elastic force of the stent to the radial direction maintains the stent fixed status at the lesion thereby maximizing the healing effect on a patient by preventing the stent moving from the lesion.
  • Also, according to the present invention, the first and second members have a crossed structure when the first and second members meet each other thereby minimizing a diameter of the stent. When the stent has the minimum diameter, the stent has the minimum volume. Therefore, the stent may be inserted easily using the introducer thereby reducing the pain of a patient.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • FIG. 1 is a perspective view illustrating a first embodiment of the present invention.
  • FIGS. 2 through 7 are developed views illustrating a working procedure of a first process.
  • FIGS. 8 through 14 are exploded views illustrating a working procedure of a second process.
  • BEST MODE FOR CARRYING OUT THE INVENTION
  • The present invention will now be described more fully with reference to the accompanying drawings, in which an exemplary embodiment of the invention is shown.
  • FIG. 1 is a perspective view of a stent manufactured by a method of the present invention. FIGS. 2 through 14 are views illustrating consecutive processes of manufacturing the stent.
  • According to an embodiment of the present invention, a stent is formed of first and second members 1 and 3. FIGS. 2 through 7 are views illustrating a process, in which the cylindrical stent is formed of the first member on a manufacturing frame. FIGS. 8 through 14 are views illustrating a process, in which a fine mesh structure is formed of the second member. The fine mesh structure is formed on the cylindrical stent formed of the first member. The first and second members 1 and 3 may be formed of a wire member, which may be coated in order to be inserted into a lumen or a lesion of a human body for a medical use. Hereinafter, the method of manufacturing the stent using a manufacturing frame J will be described in detail.
  • Referring to FIG. 1, the manufacturing frame J is cylindrical, and a plurality of pins P are disposed on a cylindrical surface on which the plurality of pins protrude in a radial direction. There are longitudinal gaps between the plurality of pins disposed on the cylindrical surface of the manufacturing frame J. Usually the gaps between the plurality of pins are same as each other, but the plurality of pins may be disposed with different gaps according to a design of the stent. It is preferable a plurality of holes are formed on the manufacturing frame J, and the plurality of pins are inserted into the plurality of holes. Referring to FIG. 2, according to the embodiment of the present invention, 9 rows of the plurality of pins (from top x1, x2, x3, . . . x9; hereinafter pin and point are same location, and a usage of pin and point is mingled for convenience) are disposed in the longitudinal direction of the stent. At this point, 9 rows are arbitrary. 14 pins (from left y1, y2, y3, . . . y13, y14, y1; since pin and point are same location, the usage of pin and point is mingled for convenience) are disposed on the first row x1 and the last row x9. Gaps between the 14 pins in the radial direction of the manufacturing frame J are identical to each other. 7 pins (y1, y3, y5, y7, y9, y11, y13) are disposed on the rows from x2 to x8. The number of pins disposed on the manufacturing frame j is not limited to this embodiment, and the stent may be manufactured using different numbers of pins.
  • Peaks and valleys are formed of the first member 1 successively from x1 to x9, in which the starting point is x1y5. The peaks and valleys of the first member are formed along the cylindrical surface of the manufacturing frame J, wherein a track of the first member 1 is bent zigzag. That is, referring to FIG. 2, the track of the first member 1 passes the points x3y3, x1y1, x3y13, x1y11, x3y9, x1y7, x5y3, x3y1, x5y13, x3y11, . . . x9y9, and x7y7. Continuously, Peaks and valleys are formed of the first member 1 successively from x9 to x1 along the cylindrical surface of the manufacturing frame J, wherein a track of the first member 1 is bent zigzag. That is, the track of the first member 1 is continued to pass the points x7y7, x9y5, x7y3, x9y1, x7y13, x9y11, x7y9, x9y7, and x5y3. When the track of the first member 1 passes the points x7y3, x7y13, x7y9, and x5y3 at which the peaks and valley meet each other, the first member 1 may be crossed and interlocked simultaneously to the preceding first member in order to keep connected status. It is preferable peaks and valleys are crossed and interlocked simultaneously when peaks and valleys meet each other, and hereinafter this description may be omitted sometimes.
  • Continuously, referring to FIGS. 4, 5, and 6, the track of the peaks and valleys of the first member 1 is continuously formed on the cylindrical surface of the manufacturing frame. That is, referring FIG. 4, the track of the first member 1 passes continuously the points x5y3, x7y1, x5y13, x7y11, x5y9, x7y7, and x3y3 in order to form the stent. Also, referring FIG. 5, the track of the first member 1 passes continuously the points x3y3, x5y1, x3y13, x5y11, x3y9, x5y7, and x1y3 in order to form the stent. In addition, referring FIG. 6, the track of the first member 1 passes continuously the points x1y3, x3y1, x1y13, x3y11, x1y9, x3y7, and x1y5 (the starting point) in order to form the stent.
  • That is, the track of the first member 1 forms the peaks and valleys on the cylindrical surface of the manufacturing frame J starting from the starting point (x1y5). The track of the first member 1 passes from the first row to the last row. Then, the track of the first member 1 continuously passes from the last row to the first row, and the track of the first member 1 meets the preceding first member 1 at the starting point (x1y5). It is preferable, according to the present invention, peaks and valleys are crossed and interlocked simultaneously whenever peaks and valleys meet each other.
  • Referring to FIG. 7, a spirally twisted strut (1 a) is formed around the preceding first member at the starting point x1y5. The strut (1 a) increases an elastic force in radial and longitudinal directions, thereby reducing a longitudinal shrinkage when the stent is inserted. Therefore, the stent may be inserted easily, and the stent may keep a fixed status at the lesion with stability.
  • FIGS. 8 through 14 are views illustrating process for reducing a mesh size of the stent formed of the first member 1 using the second member 3. That is, it is preferable the second member 3 starts from the point x1y12. The point x1y12 is a symmetrically opposite location of the starting point x1y5 of the first member 1. Also, it is preferable the second member 3 crosses about half of the meshes formed by the first member 1, when the cylindrical stent is formed of the second member 3. This will now be described more fully with reference to FIGS. 8 through 14.
  • Peaks and valleys are formed of the second member 3 starting from the point x1y12 along the cylindrical surface of the manufacturing frame J, wherein a track of the second member 3 is bent zigzag from x1 to x9 successively. At this point, it is preferable the second member 3 crosses about a half of the each mesh formed of the first member 1 in order to form meshes of half size.
  • That is, referring to FIG. 8, the track of the second member 3 passes the points x1y12, x4y9, x2y7, x4y5, x2y3, x4y1, x2y13, x6y9, x4y7, x6y5, x4y3, . . . x6y13, and x9y10. Continuously, referring to FIG. 9, peaks and valleys are formed of the second member 3 along the cylindrical surface of the manufacturing frame J, wherein a track of the second member 3 is bent zigzag from x9 to x1 successively. That is, the track of the second member 3 is continued to pass the points x9y10, x8y9, x9y8, x8y7, x9y6, x8y5, x9y4, x8y3, x9y8, x8y1, x9y14, x8y13, x9y12, and x6y9. When the track of the second member 3 passes the points x8y9, x8y5, x8y1, and x6y9, wherein the peaks and valley meet each other at those points, the second member 3 may be crossed and interlocked simultaneously in order to keep connected status. It is preferable peaks and valleys are crossed and interlocked simultaneously whenever peaks and valleys meet each other.
  • Continuously, referring FIGS. 10, 11, and 12, the peaks and valleys of the second member 3 are formed on the cylindrical surface of the manufacturing frame. That is, referring FIG. 10, the track of the second member 3 passes continuously the points x6y9, x8y7, x6y5, x8y3, x6y1, x8y13, and x4y9 in order to form the stent. Also, referring to FIG. 11, the track of the second member 3 further passes continuously the points x4y9, x6y7, x4y5, x6y3, x4y1, x6y13, and x2y9 in order to form the stent. In addition, referring to FIG. 12, the track of the second member 3 further passes continuously the points x1y10, x2y9, x1y8, x2y7, x1y6, x2y5, x1y4, x2y3, x1y2, x2y1, x1y14, x2y13, and x1y12 (the starting point of the second member 3) in order to form the stent.
  • That is, the track of the second member 3 forms the peaks and valleys on the cylindrical surface of the manufacturing frame J starting from the starting point x1y12 (x1y12 is a symmetrically opposite point of the starting point of the first member on the cylindrical surface). At this point, the track of the second member 3 passes from the first row to the last row. After then the track of the second member 3 continuously passes from the last row to the first row, and the track of the second member 3 meets the preceding second member 3 at the starting point x1y12. It is preferable, according to the present invention, peaks and valleys are crossed and interlocked simultaneously when peaks and valleys meet each other.
  • Continuously, referring to FIG. 14, another spirally twisted strut (3 a) is formed around the preceding second member at the starting point x1y12. The strut (3 a) increases an elastic force in radial and longitudinal directions, thereby reducing the longitudinal shrinkage when the stent is inserted. Therefore, the stent may be inserted easily, and the stent may keep a fixed status at the lesion with stability. It is preferable the struts (1 a and 3 a) are disposed as symmetric spirals.
  • According to the present invention, the processes for the second member are conducted after the processes for the first member 1 are completed. Accordingly, the first and second members 1 and 3 may not be interlocked each other simultaneously, and unprocessed part (the end part of the first and second members that may be wire members) of the first and second members 1 and 3 may not be damaged during the manufacturing processes. Therefore, a working efficiency is increased, and a quality of products may be improved. Specially, the manufacturing method of the present invention may form a finer mesh structure with an easy working process and thus the quality of the stent may be more improved.
  • Also, according to the present invention, the first and second members 1 and 3 are crossed and interlocked each other when they meet each other. Accordingly, when the stent is constricted, the stent has a smaller diameter than a stent formed by the prior art in which peaks and valleys are continuously interlocked each other without crossing points. Therefore, according to the present invention, the stent may be inserted using an introducer having a smaller diameter.
  • INDUSTRIAL APPLICABILITY
  • The stent may be used in a field of medical equipments. That is, the stent may be inserted into a lumen of a human body, or into a lesion of a blood vessel in order to maintain a passageway of the lumen, or the blood vessel.

Claims (8)

1. A method of manufacturing a stent, comprising:
forming a first cylindrical mesh structure by bending a first member in a zigzag-shape having peaks and valleys and a plurality of turns wound around an outer circumference of a manufacturing frame; and
forming a second cylindrical mesh structure by bending a second member in a zigzag-shape having peaks and valleys and a plurality of turns wound around an outer circumference of a manufacturing frame, wherein a bending track the second member crosses a bending track of the first member.
2. The method of claim 1, further comprising, after the first cylindrical mesh structure is formed, forming a first strut formed of a spirally twisted strut that is formed at a point where a distal end of the first member meets a proximal end of the first member.
3. The method of claim 1, further comprising, after the second cylindrical mesh structure is formed, forming a second strut formed of a spirally twisted strut that is formed at a point where a distal end of the second member meets a proximal end of the second member.
4. The method of claim 1, wherein the peaks and valleys of different turns of the first member are crossed and interlocked each other when the peaks and valleys of the different turns of the first member meet each other during the first cylindrical mesh structure is formed.
5. The method of claim 1, wherein the peaks and valleys of different turns of the second member are crossed and interlocked each other when the peaks and valleys of different turns of the second member meet each other during the second cylindrical mesh structure is formed.
6. A method of manufacturing a stent, comprising:
providing a plurality of pins on a cylindrical surface of a cylindrical manufacturing frame and setting one of a plurality of pins as a starting point;
winding a first member around the cylindrical manufacturing frame from the starting point to an end of the cylindrical manufacturing frame while being bent in a zigzag-shape to form peaks and valley with reference to the pins and having a plurality of turns;
winding the first member around the cylindrical manufacturing frame from the end of the cylindrical manufacturing frame to the starting point while being bent in a zigzag-shape to form peaks and valley with reference to the pins and having a plurality of turns, the peaks and valley are crossed and interlocked each other when the peaks and valleys meet each other;
forming a strut by spirally twisting a distal end portion of the first member and a proximal end portion of the first member after the peaks and valleys of the first member are formed;
winding a second member around the cylindrical manufacturing frame from a starting point to an end of the cylindrical manufacturing frame while being bent in a zigzag-shape to form peaks and valley with reference to the pins and having a plurality of turns, wherein the starting point of the second member is disposed on a symmetrically opposite location of the starting point of the first member on the surface of the cylindrical manufacturing frame;
winding the second member around the cylindrical manufacturing frame from the end of the cylindrical manufacturing frame to the starting point while being bent in a zigzag-shape to form peaks and valley with reference to the pins and having a plurality of turns, the peaks and valley are crossed and interlocked each other when the peaks and valleys meet each other; and
forming a strut by spirally twisting a distal end portion of the second member and a proximal end portion of the first member after the peaks and valleys of the first member are formed.
7. A stent comprising:
a first cylindrical mesh structure formed by bending a first member in a zigzag-shape having peaks and valleys and a plurality of turns wound around an outer circumference of a manufacturing frame; and
a second cylindrical mesh structure formed by bending a second member in a zigzag-shape having peaks and valleys and a plurality of turns wound around an outer circumference of a manufacturing frame, wherein a bending track the second member crosses a bending track of the first member,
wherein the first cylindrical mesh structure includes a first strut formed of a spirally twisted strut that is formed at a point where a distal end of the first member meets a proximal end of the first member; and the second cylindrical mesh structure includes a second strut formed of a spirally twisted strut that is formed at a point where a distal end of the second member meets a proximal end of the second member.
8. The stent of claim 7, wherein the peaks and valleys of the first and second members are crossed and interlocked each other as a hook shape when they meet each other.
US11/914,490 2005-07-15 2006-07-07 Stent and Method for Manufacturing the Same Abandoned US20080167709A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US13/012,946 US8210084B2 (en) 2005-07-15 2011-01-25 Stent and method for manufacturing the same

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR1020050064359A KR100633020B1 (en) 2005-07-15 2005-07-15 Stent and method for manufacturing the same
KR10-2005-0064359 2005-07-15
PCT/KR2006/002652 WO2007011122A1 (en) 2005-07-15 2006-07-07 Stent and method for manufacturing the same

Publications (1)

Publication Number Publication Date
US20080167709A1 true US20080167709A1 (en) 2008-07-10

Family

ID=37635561

Family Applications (2)

Application Number Title Priority Date Filing Date
US11/914,490 Abandoned US20080167709A1 (en) 2005-07-15 2006-07-07 Stent and Method for Manufacturing the Same
US13/012,946 Active US8210084B2 (en) 2005-07-15 2011-01-25 Stent and method for manufacturing the same

Family Applications After (1)

Application Number Title Priority Date Filing Date
US13/012,946 Active US8210084B2 (en) 2005-07-15 2011-01-25 Stent and method for manufacturing the same

Country Status (6)

Country Link
US (2) US20080167709A1 (en)
EP (1) EP1903984B1 (en)
JP (1) JP4764925B2 (en)
KR (1) KR100633020B1 (en)
CN (1) CN101184449B (en)
WO (1) WO2007011122A1 (en)

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8414635B2 (en) 1999-02-01 2013-04-09 Idev Technologies, Inc. Plain woven stents
US8419788B2 (en) 2006-10-22 2013-04-16 Idev Technologies, Inc. Secured strand end devices
US8677874B2 (en) * 2009-01-26 2014-03-25 Boston Scientific Scimed, Inc. Atraumatic stent and method and apparatus for making the same
US20160213498A1 (en) * 2012-11-08 2016-07-28 Lifetech Scientific (Shenzhen) Co., Ltd. Braided Self-Expanding Endoluminal Stent and Manufacturing Method Thereof
US20170189210A1 (en) * 2014-09-12 2017-07-06 Cg Bio Co., Ltd. Stent and method for manufacturing stent
US20180078393A1 (en) * 2015-04-15 2018-03-22 M.I.Tech Co., Ltd. Method for manufacturing stent
US20180263626A1 (en) * 2015-02-04 2018-09-20 M.I.Tech Co., Ltd. Stent for connecting adjacent tissues and manufacturing method thereof
JP2018531733A (en) * 2015-10-30 2018-11-01 ボストン サイエンティフィック サイムド,インコーポレイテッドBoston Scientific Scimed,Inc. Implantable medical device having a junction region
WO2020093066A1 (en) * 2018-11-02 2020-05-07 Microvention, Inc. Woven stent with improved deployment characteristics
US11370590B2 (en) 2015-11-18 2022-06-28 Selenium Medical Packaging, preferably medical, and corresponding assembly of packagings

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6632241B1 (en) * 2000-03-22 2003-10-14 Endovascular Technologies, Inc. Self-expanding, pseudo-braided intravascular device
US9545300B2 (en) 2004-12-22 2017-01-17 W. L. Gore & Associates, Inc. Filament-wound implantable devices
KR100633020B1 (en) 2005-07-15 2006-10-11 주식회사 스텐다드싸이텍 Stent and method for manufacturing the same
KR100847432B1 (en) * 2007-03-14 2008-07-21 주식회사 에스앤지바이오텍 Stent for expending intra luminal
JP5801037B2 (en) * 2010-05-25 2015-10-28 アクセスポイント テクノロジーズ有限会社 Stent
KR101176014B1 (en) 2010-08-06 2012-08-24 (주) 더아이엔지메디칼 Stent For Expending Lumen in Body And Inserting Device Using The Same
KR101330825B1 (en) 2011-01-14 2013-11-15 신경민 A making method for the stent and the stent thereof
CN102134781B (en) * 2011-03-16 2013-09-25 中材科技股份有限公司 Integral tube fabric structure
EP2983625B1 (en) * 2013-04-13 2024-02-14 Solinas Medical, Inc. Self-closing devices and apparatus and methods for making and delivering them
JP5939642B2 (en) * 2013-05-02 2016-06-22 日本ライフライン株式会社 Stent
KR101654861B1 (en) * 2014-08-27 2016-09-06 주식회사 비씨엠 Stent and stent method of the same
JP6470150B2 (en) 2015-09-03 2019-02-13 日本ライフライン株式会社 Stents and medical devices
KR101785042B1 (en) 2016-02-15 2017-10-12 (주) 태웅메디칼 A jig for the manufacture of the stent and which are manufactured with the manufacturing method whereby the stent using a shape memory alloy wire
JP6470219B2 (en) * 2016-03-25 2019-02-13 日本ライフライン株式会社 Stents and medical devices
KR101811634B1 (en) 2016-04-14 2017-12-27 김정권 Method for manufacturing stent
JP6072973B1 (en) * 2016-10-21 2017-02-01 株式会社北村製作所 Method for manufacturing temporary stent
KR101910952B1 (en) * 2016-10-28 2018-10-23 주식회사 넥스트바이오메디컬 Method for Calculating Diameter of stent after compression
CN108498218A (en) * 2018-05-10 2018-09-07 禾木(中国)生物工程有限公司 Intravascular stent
JP6985526B2 (en) 2018-09-21 2021-12-22 日本ライフライン株式会社 Stents and medical devices
JP6931134B2 (en) 2018-09-26 2021-09-01 日本ライフライン株式会社 Stents and stent grafts
CN111118729B (en) * 2020-01-10 2021-06-01 江苏唯德康医疗科技有限公司 Method for weaving stent and stent manufactured by using method
CN111803253B (en) * 2020-07-20 2023-05-30 河南驼人贝斯特医疗器械有限公司 Self-expanding alloy bracket and manufacturing method thereof
JPWO2022181661A1 (en) * 2021-02-26 2022-09-01
CN115844606A (en) * 2021-09-24 2023-03-28 微创优通医疗科技(嘉兴)有限公司 Bracket for intestinal tract and weaving method thereof
CN114767202B (en) * 2022-04-24 2023-03-24 惠州市顺美医疗科技有限公司 Intracranial dense mesh support and preparation method thereof
CN115553972B (en) * 2022-10-19 2023-10-20 常州乐奥医疗科技股份有限公司 Biliary tract stent manufacturing method and biliary tract stent

Citations (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5061275A (en) * 1986-04-21 1991-10-29 Medinvent S.A. Self-expanding prosthesis
US5545211A (en) * 1993-09-27 1996-08-13 Sooho Medi-Tech Co., Ltd. Stent for expanding a lumen
US5643339A (en) * 1992-08-06 1997-07-01 William Cook Europe A/S Prosthetic device for sustaining a blood-vessel or hollow organ lumen
US5746765A (en) * 1992-05-01 1998-05-05 Nitinol Medical Technologies, Inc. Stent and method and apparatus for forming and delivering the same
US5800519A (en) * 1994-04-29 1998-09-01 Kopin Corporation Tubular medical prosthesis for use in a body lumen
US6063113A (en) * 1995-06-13 2000-05-16 William Cook Europe Aps Device for implantation in a vessel or hollow organ lumen
US6221100B1 (en) * 1994-07-09 2001-04-24 Ernst Peter Strecker Endoprosthesis percutaneously inplantable in the body of a patient
US6241757B1 (en) * 1997-02-04 2001-06-05 Solco Surgical Instrument Co., Ltd. Stent for expanding body's lumen
US20020033552A1 (en) * 2000-07-31 2002-03-21 Masaaki Matsutani Method for manufacturing a stent
US20030040771A1 (en) * 1999-02-01 2003-02-27 Hideki Hyodoh Methods for creating woven devices
US6730117B1 (en) * 1998-03-05 2004-05-04 Scimed Life Systems, Inc. Intraluminal stent
US20040186549A1 (en) * 2003-03-19 2004-09-23 Swaminathan Jayaraman Braided stent with looped ends and method for making same
US20060136043A1 (en) * 2004-12-22 2006-06-22 Cully Edward H Filament-wound implantable devices
US20070203570A1 (en) * 1997-06-13 2007-08-30 Becker Gary J Expandable intraluminal endoprosthesis
US20070219618A1 (en) * 2006-03-17 2007-09-20 Cully Edward H Endoprosthesis having multiple helically wound flexible framework elements

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2089131C1 (en) * 1993-12-28 1997-09-10 Сергей Апполонович Пульнев Stent-expander
EP0754016B1 (en) 1994-04-01 2003-07-09 Prograft Medical, Inc. Self-expandable stent and stent-graft
US6165210A (en) * 1994-04-01 2000-12-26 Gore Enterprise Holdings, Inc. Self-expandable helical intravascular stent and stent-graft
US6015429A (en) * 1994-09-08 2000-01-18 Gore Enterprise Holdings, Inc. Procedures for introducing stents and stent-grafts
CN1118271C (en) * 1995-03-27 2003-08-20 守镐Medi-Tech株式会社 Stent fixed mould for expanding lumen
JP2900988B2 (en) * 1995-09-29 1999-06-02 株式会社多賀製作所 Wire bending equipment
GB9522332D0 (en) * 1995-11-01 1996-01-03 Biocompatibles Ltd Braided stent
JPH1142284A (en) * 1997-07-25 1999-02-16 Ube Ind Ltd Artificial blood vessel with stent
KR100319663B1 (en) * 1999-12-07 2002-01-05 이길환 Stent
BE1013757A6 (en) * 2000-12-12 2002-07-02 Frid Noureddine Luminal endoprosthesis MODULAR.
KR100393548B1 (en) * 2001-06-05 2003-08-02 주식회사 엠아이텍 Stent
CN2518525Y (en) * 2001-09-28 2002-10-30 上海形状记忆合金材料有限公司 Support for angionosis
US20030074051A1 (en) * 2001-10-16 2003-04-17 Kirsten Freislinger Luehrs Flexible stent
FR2847155B1 (en) * 2002-11-20 2005-08-05 Younes Boudjemline METHOD FOR MANUFACTURING A MEDICAL IMPLANT WITH ADJUSTED STRUCTURE AND IMPLANT OBTAINED THEREBY
KR100561713B1 (en) * 2003-05-23 2006-03-20 (주) 태웅메디칼 Flexible self-expandable stent and methods for making the stent
WO2004105853A1 (en) * 2003-06-02 2004-12-09 S & G Biotech, Inc. A cylindrical stent
US7445631B2 (en) * 2003-12-23 2008-11-04 Sadra Medical, Inc. Methods and apparatus for endovascularly replacing a patient's heart valve
KR100633020B1 (en) 2005-07-15 2006-10-11 주식회사 스텐다드싸이텍 Stent and method for manufacturing the same

Patent Citations (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5061275A (en) * 1986-04-21 1991-10-29 Medinvent S.A. Self-expanding prosthesis
US5746765A (en) * 1992-05-01 1998-05-05 Nitinol Medical Technologies, Inc. Stent and method and apparatus for forming and delivering the same
US5643339A (en) * 1992-08-06 1997-07-01 William Cook Europe A/S Prosthetic device for sustaining a blood-vessel or hollow organ lumen
US5545211A (en) * 1993-09-27 1996-08-13 Sooho Medi-Tech Co., Ltd. Stent for expanding a lumen
US5800519A (en) * 1994-04-29 1998-09-01 Kopin Corporation Tubular medical prosthesis for use in a body lumen
US6221100B1 (en) * 1994-07-09 2001-04-24 Ernst Peter Strecker Endoprosthesis percutaneously inplantable in the body of a patient
US6063113A (en) * 1995-06-13 2000-05-16 William Cook Europe Aps Device for implantation in a vessel or hollow organ lumen
US6241757B1 (en) * 1997-02-04 2001-06-05 Solco Surgical Instrument Co., Ltd. Stent for expanding body's lumen
US20070203570A1 (en) * 1997-06-13 2007-08-30 Becker Gary J Expandable intraluminal endoprosthesis
US20040143318A1 (en) * 1998-03-05 2004-07-22 David Tseng Intraluminal stent
US6730117B1 (en) * 1998-03-05 2004-05-04 Scimed Life Systems, Inc. Intraluminal stent
US6792979B2 (en) * 1999-02-01 2004-09-21 Board Of Regents, The University Of Texas System Methods for creating woven devices
US20030040771A1 (en) * 1999-02-01 2003-02-27 Hideki Hyodoh Methods for creating woven devices
US20020033552A1 (en) * 2000-07-31 2002-03-21 Masaaki Matsutani Method for manufacturing a stent
US20040186549A1 (en) * 2003-03-19 2004-09-23 Swaminathan Jayaraman Braided stent with looped ends and method for making same
US20060136043A1 (en) * 2004-12-22 2006-06-22 Cully Edward H Filament-wound implantable devices
US20070219618A1 (en) * 2006-03-17 2007-09-20 Cully Edward H Endoprosthesis having multiple helically wound flexible framework elements

Cited By (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8876880B2 (en) 1999-02-01 2014-11-04 Board Of Regents, The University Of Texas System Plain woven stents
US9925074B2 (en) 1999-02-01 2018-03-27 Board Of Regents, The University Of Texas System Plain woven stents
US8414635B2 (en) 1999-02-01 2013-04-09 Idev Technologies, Inc. Plain woven stents
US8974516B2 (en) 1999-02-01 2015-03-10 Board Of Regents, The University Of Texas System Plain woven stents
US9408730B2 (en) 2006-10-22 2016-08-09 Idev Technologies, Inc. Secured strand end devices
US8419788B2 (en) 2006-10-22 2013-04-16 Idev Technologies, Inc. Secured strand end devices
US8739382B2 (en) 2006-10-22 2014-06-03 Idev Technologies, Inc. Secured strand end devices
US9149374B2 (en) 2006-10-22 2015-10-06 Idev Technologies, Inc. Methods for manufacturing secured strand end devices
US8966733B2 (en) 2006-10-22 2015-03-03 Idev Technologies, Inc. Secured strand end devices
US9895242B2 (en) 2006-10-22 2018-02-20 Idev Technologies, Inc. Secured strand end devices
US10470902B2 (en) 2006-10-22 2019-11-12 Idev Technologies, Inc. Secured strand end devices
US9408729B2 (en) 2006-10-22 2016-08-09 Idev Technologies, Inc. Secured strand end devices
US9585776B2 (en) 2006-10-22 2017-03-07 Idev Technologies, Inc. Secured strand end devices
US9629736B2 (en) 2006-10-22 2017-04-25 Idev Technologies, Inc. Secured strand end devices
US8677874B2 (en) * 2009-01-26 2014-03-25 Boston Scientific Scimed, Inc. Atraumatic stent and method and apparatus for making the same
US11840780B2 (en) 2009-01-26 2023-12-12 Boston Scientific Scimed, Inc. Atraumatic stent and method and apparatus for making the same
US9388517B2 (en) 2009-01-26 2016-07-12 Boston Scientific Scimed, Inc. Atraumatic stent and method and apparatus for making the same
US11578437B2 (en) 2009-01-26 2023-02-14 Boston Scientific Scimid, Inc. Atraumatic stent and method and apparatus for making the same
US10947651B2 (en) 2009-01-26 2021-03-16 Boston Scientific Scimed, Inc. Atraumatic stent and method and apparatus for making the same
US20160213498A1 (en) * 2012-11-08 2016-07-28 Lifetech Scientific (Shenzhen) Co., Ltd. Braided Self-Expanding Endoluminal Stent and Manufacturing Method Thereof
US10251763B2 (en) * 2012-11-08 2019-04-09 Lifetech Scientific (Shenzhen) Co. Ltd. Braided self-expanding endoluminal stent and manufacturing method thereof
US20170189210A1 (en) * 2014-09-12 2017-07-06 Cg Bio Co., Ltd. Stent and method for manufacturing stent
US10617421B2 (en) * 2015-02-04 2020-04-14 M.I. Tech Co., Ltd. Stent for connecting adjacent tissues and manufacturing method thereof
US20180263626A1 (en) * 2015-02-04 2018-09-20 M.I.Tech Co., Ltd. Stent for connecting adjacent tissues and manufacturing method thereof
US10449068B2 (en) * 2015-04-15 2019-10-22 M.I.Tech Co., Ltd. Method for manufacturing stent
US20180078393A1 (en) * 2015-04-15 2018-03-22 M.I.Tech Co., Ltd. Method for manufacturing stent
JP2018531733A (en) * 2015-10-30 2018-11-01 ボストン サイエンティフィック サイムド,インコーポレイテッドBoston Scientific Scimed,Inc. Implantable medical device having a junction region
US11370590B2 (en) 2015-11-18 2022-06-28 Selenium Medical Packaging, preferably medical, and corresponding assembly of packagings
WO2020093066A1 (en) * 2018-11-02 2020-05-07 Microvention, Inc. Woven stent with improved deployment characteristics

Also Published As

Publication number Publication date
WO2007011122A1 (en) 2007-01-25
EP1903984B1 (en) 2016-10-19
EP1903984A1 (en) 2008-04-02
CN101184449A (en) 2008-05-21
EP1903984A4 (en) 2014-11-19
KR100633020B1 (en) 2006-10-11
JP4764925B2 (en) 2011-09-07
US20110125250A1 (en) 2011-05-26
CN101184449B (en) 2010-06-16
US8210084B2 (en) 2012-07-03
JP2009501049A (en) 2009-01-15

Similar Documents

Publication Publication Date Title
US8210084B2 (en) Stent and method for manufacturing the same
US20240032938A1 (en) Embolic devices and methods of manufacturing same
US10857589B2 (en) Three-dimensional complex coil
JP2975584B2 (en) Body expansion stent
DE69533985T2 (en) STENT
KR100455975B1 (en) Inflatable stent
US20030105515A1 (en) Stent designs
DE202013012692U1 (en) Stent and stent delivery device
WO2008016626A2 (en) Helical stent
KR101320480B1 (en) Flexible stent
US8998975B2 (en) Helical stent with orthogonal end and method of forming stent
WO2023140214A1 (en) Stent
KR102264171B1 (en) Stent and Manufacturing Method thereof
KR100190755B1 (en) Medical appliance for expansion of lumen and manufacturing method thereof
CN219074239U (en) Biliary tract support manufacturing clamp
KR19990065081A (en) Lumen extension stent
KR20020072698A (en) Extended intravascular stent configured by combining multi stent lines
CN115889619A (en) Biliary tract stent manufacturing clamp and biliary tract stent manufacturing method

Legal Events

Date Code Title Description
AS Assignment

Owner name: STANDARD SCI-TECH, INC., KOREA, REPUBLIC OF

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:AN, SUNG-SOON;REEL/FRAME:020163/0251

Effective date: 20071109

Owner name: STANDARD SCI-TECH, INC., KOREA, REPUBLIC OF

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:AN, SUNG-SOON;REEL/FRAME:020164/0882

Effective date: 20071109

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION